NFKB1 and acute myeloid leukemia: Furthermore, inducing alkaliptosis is proposed as a therapeutic approach to overcome venetoclax resistance in AML cells, and targeting NF-κB-dependent alkaliptosis has shown promise in treating venetoclax-resistant AML [149].